Author: Mohammadi, Elmira; Shafiee, Fatemeh; Shahzamani, Kiana; Ranjbar, Mohammad Mehdi; Alibakhshi, Abbas; Ahangarzadeh, Shahrzad; Beikmohammadi, Leila; Shariati, Laleh; Hooshmandi, Soodeh; Ataei, Behrooz; Javanmard, Shaghayegh Haghjooy
                    Title: Novel and emerging mutations of SARS-CoV-2: Biomedical implications  Cord-id: rlw166s1  Document date: 2021_4_23
                    ID: rlw166s1
                    
                    Snippet: Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 virus strains has geographical diversity associated with diverse severity, mortality rate, and response to treatment that were characterized using phylogenetic network analysis of SARS-CoV-2 genomes. Although, there is no explicit and integrative explanation for these variations, the genetic arrangement, and stability of SARS-CoV-2 are basic contributing factors to its viru
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 virus strains has geographical diversity associated with diverse severity, mortality rate, and response to treatment that were characterized using phylogenetic network analysis of SARS-CoV-2 genomes. Although, there is no explicit and integrative explanation for these variations, the genetic arrangement, and stability of SARS-CoV-2 are basic contributing factors to its virulence and pathogenesis. Hence, understanding these features can be used to predict the future transmission dynamics of SARS-CoV-2 infection, drug development, and vaccine. In this review, we discuss the most recent findings on the mutations in the SARS-CoV-2, which provide valuable information on the genetic diversity of SARS-CoV-2, especially for DNA-based diagnosis, antivirals, and vaccine development for COVID-19.
 
  Search related documents: 
                                Co phrase  search for related documents- accessory protein and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48
  - acid damage and acute respiratory syndrome: 1, 2, 3
  - acute respiratory syndrome and adenosine deaminase: 1
  - acute respiratory syndrome and low mutation rate: 1, 2
  - adar rna dependent adenosine deaminase and adenosine deaminase: 1
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date